GloGloCo-founder
Until Present
Marie Schneegans is co-founder of GloGlo, which combines AI research and experimental biology to work toward treatments for autoimmune disease, starting with type 1 diabetes. Its consumer products include glucose support gummies and an AI companion. She also co-founded 14.ai and Workwell. She is a member of the Interact Fellowship, where she has hosted founder dinners.
Marie Schneegans is co-founder of GloGlo, which combines AI research and experimental biology to work toward treatments for autoimmune disease, starting with type 1 diabetes. Its consumer products include glucose support gummies and an AI companion. She also co-founded 14.ai and Workwell. She is a member of the Interact Fellowship, where she has hosted founder dinners.